Recent Quarter Total Invested
$240.07 M
Recent Quarter Institutional Ownership Percentage
87.14%
Total Invested of Last Quarter
$382.04 M
Ownership Percentage of Last Quarter
96.21%
Inozyme Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 5.73 M | $25.55 M | 7.51% | 9.27% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 4.49 M | $20.05 M | 0.00% | 7.28% |
| SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 4.28 M | $19.09 M | 0.00% | 6.93% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 3.94 M | $17.56 M | 23.79% | 6.37% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 3.70 M | $16.49 M | 0.47% | 5.99% |
| SAMLYN CAPITAL, LLC | 08/14/2024 | 3.35 M | $14.94 M | 15.02% | 5.42% |
| BLACKROCK INC. | 08/13/2024 | 3.34 M | $14.91 M | 8.24% | 5.41% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 2.86 M | $12.74 M | 8.09% | 4.62% |
| VANGUARD GROUP INC | 08/13/2024 | 2.63 M | $11.73 M | 8.69% | 4.26% |
| FMR LLC | 08/13/2024 | 2.48 M | $11.05 M | 25.92% | 4.01% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2024 | 2.44 M | $10.87 M | 0.00% | 3.95% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.79 M | $7.97 M | 154.11% | 2.89% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 1.56 M | $6.97 M | 0.00% | 2.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2024 | 1.46 M | $6.52 M | 6.54% | 2.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.15 M | $5.14 M | 7.89% | 1.86% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.14 M | $5.09 M | 100.00% | 1.85% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/15/2024 | 1.12 M | $5.00 M | -11.81% | 1.81% |
| WOODLINE PARTNERS LP | 08/14/2024 | 1.00 M | $4.46 M | 12.68% | 1.62% |
| STATE STREET CORP | 08/14/2024 | 1.00 M | $4.46 M | 13.56% | 1.62% |
| KNOTT DAVID M JR | 08/12/2024 | 564,549 | $2.52 M | 0.00% | 0.91% |
| NORTHERN TRUST CORP | 08/14/2024 | 411,376 | $1.83 M | -2.03% | 0.67% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 380,064 | $1.70 M | 117.62% | 0.62% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 361,868 | $1.61 M | -11.72% | 0.59% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 232,980 | $1.04 M | -4.59% | 0.38% |
| OVERBROOK MANAGEMENT CORP | 07/25/2024 | 219,326 | $978,194 | 0.00% | 0.36% |
| UBS OCONNOR LLC | 08/14/2024 | 205,218 | $915,272 | 12.01% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 190,896 | $851,397 | 16.09% | 0.31% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 187,839 | $837,762 | 8.14% | 0.30% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 160,879 | $717,520 | 0.00% | 0.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 143,158 | $638,485 | 13.14% | 0.23% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 140,022 | $624,498 | 133.78% | 0.23% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 126,541 | $564,373 | -68.54% | 0.20% |
| MORGAN STANLEY | 10/17/2024 | 78,898 | $351,885 | -36.50% | 0.13% |
| RHUMBLINE ADVISERS | 08/01/2024 | 77,004 | $343,426 | 21.96% | 0.12% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 57,100 | $254,666 | 11.03% | 0.09% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 55,186 | $246,000 | 100.00% | 0.09% |
| ALPS ADVISORS INC | 08/13/2024 | 48,263 | $215,253 | 10.80% | 0.08% |
| JANE STREET GROUP, LLC | 08/15/2024 | 46,017 | $205,236 | 58.22% | 0.07% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 40,931 | $183,000 | -68.78% | 0.07% |
| PALE FIRE CAPITAL SE | 08/13/2024 | 38,901 | $173,498 | 100.00% | 0.06% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 32,650 | $145,619 | 78.61% | 0.05% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 29,600 | $132,016 | -28.33% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/13/2024 | 27,949 | $124,653 | 45.52% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 08/14/2024 | 27,811 | $124,037 | 100.00% | 0.05% |
| CITADEL ADVISORS LLC | 08/14/2024 | 25,895 | $115,492 | -72.07% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 24,405 | $108,846 | 100.00% | 0.04% |
| BAILARD, INC. | 07/25/2024 | 24,300 | $108,378 | 0.00% | 0.04% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 22,713 | $101,300 | 34.73% | 0.04% |
| JPMORGAN CHASE & CO | 08/12/2024 | 22,077 | $98,464 | -64.15% | 0.04% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 21,427 | $95,564 | 14.36% | 0.03% |
Inozyme Pharma, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of INZY shares?
During the previous two years, 100 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:
ROTHSCHILD INVESTMENT LLC: 0
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.73 M
Pivotal bioVenture Partners Investment Advisor LLC: 4.49 M
Sofinnova Investments, Inc.: 4.28 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.94 M
Rock Springs Capital Management LP: 3.7 M
-
What percentage of Inozyme Pharma, Inc. stock is owned by institutional investors?
87.14% of Inozyme Pharma, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at INZY ?
Institutional investors have bought a total of 55.27 M shares in the last 24 months. This purchase volume represents approximately $236.01 M in transactions.